Navigation Links
GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg)

Entereg studies, changing regulatory requirements, the risk that the FDA may not agree with Adolor's and GSK's analyses of the Entereg studies (including Study 014) and may evaluate the results of these studies by different methods or conclude that the results from the studies, whether or not statistically significant, do not support safety, efficacy, a favorable risk/benefit profile, or there were human errors in the conduct of the studies, or otherwise; adverse safety findings in any Entereg studies; the risk that regulatory approvals for the use of Entereg in OBD are not achieved; the risk that filing targets for regulatory submissions or user fee goal dates are not met; the risk that the results of other clinical trials of Adolor's drug product candidates, including Entereg, are not positive; the risk of product liability claims; reliance on third party manufacturers; the costs, delays and uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process; Adolor's history of operating losses since inception and its need for additional funds to operate its business; Adolor's reliance on its collaborators, including GSK, in connection with the development and commercialization of Entereg; market acceptance of Adolor's products, if regulatory approval is achieved; competition; and securities litigation.

Further information about these and other relevant risks and uncertainties may be found in Adolor's Reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Adolor urges you to carefully review and consider the disclosures found in its filings which are available in the SEC EDGAR database at http://www.sec.gov and from Adolor at http://www.adolor.com. Given the uncertainties affecting pharmaceutical companies in the development stage, you are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/22/2014)... 22, 2014  As the Medical Affairs, role has ... in this area are exploring methods to develop strong ... Affairs Consortium at Best Practices, LLC is designed to ... about the key challenges they face. The consortium will ... three virtual roundtable discussions where leaders discuss key findings ...
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6
... 2011 The U.S. Food and Drug Administration today ... sting by Centruroides scorpions in the United ... Venomous scorpions in the U.S. are mostly ... infants and children, and can cause shortness of breath, ...
... CPHD ) today announced that its executives will ... to participate via webcast. Canaccord Genuity Growth Conference, ... Time Wedbush 2011 Life Sciences Conference, New York, ... Baird 2011 Health Care Conference, New York, NY ...
Cached Medicine Technology:FDA Approves the First Specific Treatment for Scorpion Stings 2Cepheid to Webcast Upcoming Financial Presentations 2
(Date:8/23/2014)... (PRWEB) August 23, 2014 Young adults in Athens, ... doing drugs should pick up the phone and call the new ... teen drug addict . , Troubled Teen Athens is a ... ready to finally take the necessary steps to end substance abuse ... are quick to go to friends or peers when really they ...
(Date:8/23/2014)... is almost over and before we know it schools and ... supplies and a new wardrobe might take precedence over the ... spend some time brushing up on bed bug prevention tips. ... populated places,” said Randy Rupert, Bed Bug Team Lead at ... bed bugs to take up residence.” , An already notorious ...
(Date:8/22/2014)... 23, 2014 Recently, Skmen.com, an experienced ... of 2014 bohemian dresses in its online store. Moreover, ... prices, up to 28% off. All the international clients ... August 31, 2014. , The company’s professional online ... to show worldwide customers more the latest information about ...
(Date:8/22/2014)... Recently, UWDress.com, a leading online supplier of ... new range of empire bridesmaid dresses to its ... a summer promotion for these high quality items. All of ... to 75 percent off. , The company’s new items ... efficient assistance on its website. It is true that all ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Millennium Treatment Group ... resulting in a high level of drug use among teenagers. ... fight against drug addiction and work to minimize drug abuse. ... of alcohol and drug addiction in history. According to the ... estimated 23.9 million Americans aged 12 or older—or 9.2 percent ...
Breaking Medicine News(10 mins):Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... ,Child-Friendly Spaces, to help children cope with ... disaster - Children have ... ... YANGON, Myanmar, May 14 World Vision is addressing the,emotional and physical needs of children ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, ... China, is a vertically integrated specialty,pharmaceutical company. ... AMDL engages in the research, development, manufacture, ... products currently in China. The Company today ...
... St. Louis, PLEASANT GROVE, Utah, May 14 ... pleased to,announce the inclusion of Myo-Med in the new ... Meeting in St. Louis, MO,June 17-21. The company launched ... a favorite with top athletes. Among those endorsing,Myo-Med are ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) announced today that ... the Securities and Exchange,Commission (the "Commission"), as required ... tender offer (the "Offer") by RWD Acquisition I,LLC ... shares of the common,stock of Pharmacyclics, Inc. (the ...
... NARAL Pro-Choice,America endorsed Senator Barack Obama for President., ... Pro-Choice America, based in,Washington D.C., and without the ... NARAL Pro-Choice Pennsylvania will not be issuing ... that this endorsement in,the Democratic primary is premature. ...
... Inc.,(Nasdaq: CPTS ) developer of the Essure(R) ... method available, today reported,that Medi-Cal, California,s state fee-for-service ... or disabled women in California,now have a safe ... not require the general anesthesia, incisions or long ...
Cached Medicine News:Health News:Myanmar: Half a Million Children Affected by Cyclone, Aid Agency Warns 2Health News:Myanmar: Half a Million Children Affected by Cyclone, Aid Agency Warns 3Health News:AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort 2Health News:Toxin-Free Pain Cream to Make First Appearance at Athletic Trainer Event 2Health News:Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission 2Health News:Essure Procedure Now Covered by Medicaid in California 2Health News:Essure Procedure Now Covered by Medicaid in California 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: